Precision therapy for acute myeloid leukemia

Precision therapy for acute myeloid leukemia

Abstract Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous disease. Despite advances in understanding the pathogenesis of AML, the standard therapy remained nearly unchanged over the past three decades. With the poor survival for older patients and high relapse rate, multipl...

Full description

Bibliographic Details
Main Authors: Xue Yang, Jianxiang Wang
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Journal of Hematology & Oncology
Subjects:
Acute myeloid leukemia
Precision therapy
Conventional chemotherapies
Molecular targeted inhibitors
Epigenetic mutations
Immunotherapy
Online Access:http://link.springer.com/article/10.1186/s13045-017-0543-7

Internet

http://link.springer.com/article/10.1186/s13045-017-0543-7

Similar Items